慢性淋巴细胞白血病靶向治疗研究进展:第54届美国血液学会年会报道 |
| |
引用本文: | 陈昱函,张可杰. 慢性淋巴细胞白血病靶向治疗研究进展:第54届美国血液学会年会报道[J]. 白血病.淋巴瘤, 2013, 22(4): 193-201 |
| |
作者姓名: | 陈昱函 张可杰 |
| |
作者单位: | 361004,厦门大学医学院;厦门大学附属中山医院血液科 |
| |
摘 要: | 近年来,针对慢性淋巴细胞白血病(CLL)细胞增殖和存活关键信号转导通路的小分子靶向治疗备受关注,并逐渐形成了CLL的治疗新模式。现对CLL新的治疗模式及2012年第54届美国血液学会(ASH)年会相关进展进行概述。
|
关 键 词: | 白血病 淋巴细胞 慢性 靶向治疗 美国血液学会年会 |
Advances in the targeted therapy for chronic lymphocytic leukemia in the 54th ASH annual meeting |
| |
Abstract: | Recognition has been achieved in the molecular targeting of several key signaling transduction pathways governing cell survival and proliferation in chronic lymphocytic leukemia (CLL). A milestone in CLL treatment is reached. This review provides a brief summary of the 54th ASH annual meeting, focusing on recent advances in the preclinical and clinical investigation of promising target-directed therapeutic agents. |
| |
Keywords: | Leukemia, lymphocytic, chronic Targeted therapy ASH annual meeting |
本文献已被 万方数据 等数据库收录! |
| 点击此处可从《白血病.淋巴瘤》浏览原始摘要信息 |
|
点击此处可从《白血病.淋巴瘤》下载全文 |